RecruitingNCT02829437

Observational Study on Endometrial Stromal Tumors

Endometrial Stromal Tumors: an Observational Study

Sponsor

Italian Sarcoma Group

Enrollment

100 participants

Start Date

Oct 1, 2016

Study Type

OBSERVATIONAL

Conditions

Endometrial Stromal Tumors

Summary

Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014
Informed consent signature

Exclusion Criteria1

patients with different diagnosis from EST

Interventions

OTHERTreatment for EST

Surgery and/or Chemotherapy and or/radiotherapy for EST treatment according to disease guidelines: no specific treatment is imposed by protocol (observational study)

Locations(13)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST

Meldola, FC, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, MI, Italy

Istituto Europeo di Oncologia

Milan, MI, Italy

Azienda Ospedaliera Universitaria Paolo Giaccone

Palermo, PA, Italy

Centro di Riferimento Oncologico di Aviano

Aviano, PD, Italy

Istituto Oncologico Veneto

Padua, PD, Italy

Fondazione del Piemonte per l'Oncologia IRCC Candiolo

Candiolo, Torino, Italy

Policlinico S.Orsola Malpighi - Unit of Medical Oncology

Bologna, Italy

Azienda Ospedaliera Universitaria Careggi

Florence, Italy

Azienda Ospedaliero-Universitaria Careggi

Florence, Italy

Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4

Prato, Italy

Campus Biomedico

Roma, Italy

Istituti Fisioterapici Ospitalieri di Roma

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02829437